EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial

Constance H Fung iD, Selene Mak iD, Garrett Ash, Erin Der-McLeod, B S Jason Ereso, Saadia Naeem, Jinhui Liu, Sara Ghadimi iD, Tue T Te, Vivian Chan iD, Jennifer Hurtado, Sarah Wong und 2 weitere

SLEEPJ · 2026

DOI: 10.1093/sleep/zsaf342 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift SLEEPJ, 2026. Verfasst von Constance H Fung und 13 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Wearable Electronic Devices, Continuous Positive Airway Pressure. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study Objectives This pilot randomized trial measured the effects of a consumer-grade wearable-augmented program, which provides nightly pulse oximetry data to patients in a weekly report, on positive airway pressure (PAP) use in adults with obstructive sleep apnea (OSA) recruited from an outpatient sleep center.

Methods

This single-blind, parallel, two-group waitlist-controlled, single-site randomized trial recruited individuals with OSA with insufficient PAP use from a Department of Veterans Affairs medical center and randomized them to immediate participation in the consumer wearable-augmented self-monitoring program versus waitlist. The primary outcome was the change in modem-measured PAP use (mean hours or minutes per night over a 7-day period) from baseline (T1) to T3 assessment, which was 35 days following randomization (7 days post-intervention for the immediate group and prior to intervention for the waitlist group).

Results

We randomized 50 participants (mean age 47.9 years [SD 11.4]; 88% male). The change in PAP use was +1.33 hours (+79.8 minutes) for the immediate group and −0.17 hours (−10.2 minutes) for the waitlist control group, with a between-group difference of 1.50 hours (90 minutes) (p = .0097). The change in the number of days PAP was used for 4 hours or more over a 7-day period was +1.32 days for the immediate and 0.12 days for the waitlist control group, with a between-group difference of 1.20 (p = .0401).

Conclusions

This pilot trial demonstrated that the consumer-grade wearable-augmented program is a promising intervention for increasing PAP use. A future full-scale trial that follows participants for a longer period is needed. Statement of Significance This pilot trial tested a novel use of the pulse oximetry feature available on some consumer-grade wearable devices to increase use of positive airway pressure (PAP) devices among adults with obstructive sleep apnea (OSA) and insufficient PAP use. The widespread and growing use of consumer-grade wearable devices offers an opportunity to leverage the features on these devices to tackle a common, problematic issue among individuals with OSA—insufficient use of PAP therapy. The randomized controlled design provides support for future research involving these devices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sleep Apnea, ObstructiveWearable Electronic DevicesContinuous Positive Airway PressureHumansMalePilot ProjectsFemaleMiddle AgedSingle-Blind MethodAdultOximetry

Stichwörter der Autor:innen

adherenceconsumer sleep technologyobstructive sleep apnea–PAP therapy

Autor:innen und Institutionen

  • Geriatric Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
  • Department of Medicine, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States.
  • Center for the Study of Healthcare Innovation, Implementation and Policy, VA Greater Los Angeles Healthcare System, Los Angeles, CA, United States.
  • Department of Internal Medicine, VA Connecticut and Yale School of Medicine, West Haven, CT, United States.
  • Department of Medicine Statistics Core, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, United States.
  • Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, Las Vegas, NV, United States.

ORCID-Profile: Constance H Fung, Selene Mak, Sara Ghadimi, Vivian Chan, Li-Jung Liang

Förderung

  • NIA NIH HHS

Zitieren

APA

Fung, C. H., Mak, S., Ash, G., Der-McLeod, E., Jason Ereso, B. S., Naeem, S., Liu, J., Ghadimi, S., Te, T. T., Chan, V., Hurtado, J., Wong, S., Zeidler, M., & Liang, L. J. (2026). Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial. SLEEPJ. https://doi.org/10.1093/sleep/zsaf342

Vancouver

Fung CH, Mak S, Ash G, Der-McLeod E, Jason Ereso BS, Naeem S, et al. Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial. SLEEPJ. 2026. doi:10.1093/sleep/zsaf342

BibTeX
@article{Fung2026,
  author = {Fung, Constance H and Mak, Selene and Ash, Garrett and Der-McLeod, Erin and Jason Ereso, B S and Naeem, Saadia and Liu, Jinhui and Ghadimi, Sara and Te, Tue T and Chan, Vivian and Hurtado, Jennifer and Wong, Sarah and Zeidler, Michelle and Liang, Li-Jung},
  title = {Augmenting management of obstructive sleep apnea with consumer wearable devices to increase use of positive airway pressure therapy: a pilot randomized trial},
  journal = {SLEEPJ},
  year = {2026},
  doi = {10.1093/sleep/zsaf342}
}
Kostenlos starten →